Continuous, automated, real-time monitoring of key biomarkers
The MicroEye® delivers a simple, reliable and cost-effective continuous tissue sampling system suitable for measuring a range of substances including glucose, lactate, drugs and other biomarkers.
Traditional methods of blood and tissue sampling can only give you snapshots of data at intervals, but this misses out important data trends as well as sharp peaks and troughs, critical information when determining care.
Our point-of-care MicroEye® device can measure several biomarkers including lactate, immunosuppressants, antibiotics and analytes while the blood or tissue stays in the patient – where it belongs – and avoids time-consuming lab sampling.
Comparison of traditional blood draw results v MicroEye®
MicroEye® enables real-time biomarker/analyte sampling by delivering dialysate to an external sensor system to provides continuous and automated data. Removes the need for repeated sample withdrawal, and transportation to the lab for testing.
The MicroEye® enables real-time continuous monitoring of drugs in patients for effective therapeutic drug monitoring. Study on transplant patients receiving immunosuppressants successfully completed in Munich. Other drug studies on-going.
The MicroEye® has been integrated with custom sensors and other monitoring devices including the company’s own ContinuMon® system, allowing clinicians to view data and trends using portable user-interfaces.
The MicroEye® is already non-exclusively licenced to Menarini Diagnostics for continuous glucose monitoring.
We are are interested in hearing from commercial and academic organisations who would like to explore the benefits of our MicroEye® technology.